Holtzman's group reviews multiple molecular mechanisms by which sleep disturbance and disruption of circadian rhythms may affect AD pathogenesis. In addition, they discuss potential therapeutic strategies for AD by targeting the circadian clock and sleep-wake system.
Bhumsoo Kim and Eva L Feldman focus on the dysfunction of insulin signaling in AD pathogenesis. Insulin signaling has diverse roles in the brain, such as cognition, memory, synaptic plasticity and neurogenesis. As AD patients show the disrupted glucose metabolism in the brain, it is reasonable to link insulin resistance and AD pathogenesis. The authors also suggest that several diabetes therapies targeting insulin signaling may have potential therapeutic benefits in AD patients.
Mook-Jung's gourp review the mitochondrial dysfunction in several neurodegenerative diseases, including AD. Reactive oxygen species (ROS) is a well-known stress factor for the central nervous system. ROS induces mutations in mitochondrial genes, leading to more ROS generation by exacerbating mitochondrial dysfunction. This vicious cycle between ROS and mitochondrial dysfunction further stresses neurons, eventually leading to cell death. Antioxidant therapy restoring mitochondrial function might be one of potential therapeutic strategies to treat AD and other neurodegenerative disorders.
Proper maintenance of neuronal circuits is critical for learning and memory. The loss of neurons and neuronal processes directly contributes to cognitive declines in AD. Because many clinical trials with small molecule approaches, as well as anti-Aβ immunotherapy has failed, cell replacement therapy using human embryonic stem cell-or induced pluripotent stem cell -derived neural cells is gaining attention as a potential treatment for AD. Huang's group reviews the current status and future prospects of stem cell therapy for AD and other related disorders.
Because AD and other age-associated neurodegenerative disorders are chronic diseases, many factors might be involved in the onset and progression of these diseases. The five articles in this special issue provide comprehensive reviews of the multiple pathogenic mechanisms underlying AD and related neurodegenerative disorders. In addition, each review suggests potential therapeutic targets for the treatment of AD. 
